Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
Stock Summary
Top Correlated Resources
192820.KS
Top 10 Correlated ETFs
192820.KS
Top 10 Correlated Stocks
192820.KS
Financial details
Company Rating
Strong Buy
Market Cap
702.3B
Income
53.13B
Revenue
1619.04B
Book val./share
53604.33
Cash/share
-
Dividend
550
Dividend %
0.97%
Employees
1.15K
Optionable
No
Shortable
Yes
Earnings
08 Nov 2022
P/E
12.13
Forward P/E
-
PEG
1.81
P/S
0.4
P/B
1.06
P/C
-
P/FCF
11.59
Quick Ratio
-
Current Ratio
0.94
Debt / Equity
-
LT Debt / Equity
-
-
-
EPS (TTM)
3.49K
EPS next Y
-
EPS next Q
-
EPS this Y
232.1%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
30.36%
Revenue last 5Y
12.48%
Revenue Q/Q
1.8%
EPS Q/Q
-24.82%
-
-
-
-
SMA20
-5.93%
SMA50
2.83%
SMA100
-27.4%
Inst Own
-
Inst Trans
-
ROA
4%
ROE
9%
ROC
0.14%
Gross Margin
16%
Oper. Margin
5%
Profit Margin
3%
Payout
12%
Shs Outstand
11.35M
Shs Float
8.07M
-
-
-
-
Target Price
-
52W Range
54300.0-141500.0
52W High
-59.86%
52W Low
+4.6%
RSI
35.02
Rel Volume
3.3
Avg Volume
77.8K
Volume
257.12K
Perf Week
-5.96%
Perf Month
-15.35%
Perf Quarter
-32.06%
Perf Half Y
-29.35%
-
-
-
-
Beta
0.638034
-
-
Volatility
1875.19%, 2767.25%
Prev Close
-7.19%
Price
56800
Change
-10.41%
Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2021-12-31
| Metric | History | 2021-12-31 |
|---|---|---|
| Revenue per share | 148.48K | |
| Net income per share | 6.94K | |
| Operating cash flow per share | 9.33K | |
| Free cash flow per share | 5.41K | |
| Cash per share | 17.2K | |
| Book value per share | 52.37K | |
| Tangible book value per share | 38.72K | |
| Share holders equity per share | 52.37K | |
| Interest debt per share | 54.18K | |
| Market cap | 761.04B | |
| Enterprise value | 1224.45B | |
| P/E ratio | 10.22 | |
| Price to sales ratio | 0.48 | |
| POCF ratio | 7.61 | |
| PFCF ratio | 13.14 | |
| P/B Ratio | 1.36 | |
| PTB ratio | 1.36 | |
| EV to sales | 0.77 | |
| Enterprise value over EBITDA | 6.52 | |
| EV to operating cash flow | 12.24 | |
| EV to free cash flow | 21.13 | |
| Earnings yield | 0.1 | |
| Free cash flow yield | 0.08 | |
| Debt to equity | 0.2 | |
| Debt to assets | 0.67 | |
| Net debt to EBITDA | 2.47 | |
| Current ratio | 1.01 | |
| Interest coverage | 7 | |
| Income quality | 1.34 | |
| Dividend Yield | 0 | |
| Payout ratio | 0 | |
| Sales general and administrative to revenue | 0.01 | |
| Research and developement to revenue | 0 | |
| Intangibles to total assets | 0.04 | |
| Capex to operating cash flow | -0.42 | |
| Capex to revenue | -0.03 | |
| Capex to depreciation | -0.81 | |
| Stock based compensation to revenue | 0 | |
| Graham number | 90.46K | |
| ROIC | 0.2 | |
| Return on tangible assets | 0.05 | |
| Graham Net | -60.68K | |
| Working capital | 4.57B | |
| Tangible asset value | 415.07B | |
| Net current asset value | -154.31B | |
| Invested capital | 1 | |
| Average receivables | 0 | |
| Average payables | 164.79B | |
| Average inventory | 208.44B | |
| Days sales outstanding | 0 | |
| Days payables outstanding | 51.86 | |
| Days of inventory on hand | 62.1 | |
| Receivables turnover | 0 | |
| Payables turnover | 7.04 | |
| Inventory turnover | 5.88 | |
| ROE | 0.13 | |
| Capex per share | -3.93K |
Quarterly Fundamentals Overview
Last date of statement is 2022-06-30 for Q2
| Metric | History | 2021-09-30 | 2021-12-31 | 2022-03-31 | 2022-06-30 |
|---|---|---|---|---|---|
| Revenue per share | 34.81K | 4K | 35.07K | 35.7K | |
| Net income per share | 985 | 144.32 | 1.35K | 1.01K | |
| Operating cash flow per share | 1.24K | 509.73 | 2.49K | -59.45 | |
| Free cash flow per share | 347.99 | 412.34 | 1.58K | -847.81 | |
| Cash per share | 16.41K | 1.75K | 16.15K | 0 | |
| Book value per share | 47.84K | 5.33K | 51.08K | 53.6K | |
| Tangible book value per share | 36.05K | 3.94K | 37.53K | 43.28K | |
| Share holders equity per share | 47.84K | 5.33K | 51.08K | 53.6K | |
| Interest debt per share | 52.74K | 5.39K | 49.47K | 37.76 | |
| Market cap | 1412.49B | 9195.88B | 948.5B | 641.03B | |
| Enterprise value | 1822.8B | 9659.3B | 1386.49B | 641.03B | |
| P/E ratio | 31.6 | 151.4 | 15.52 | 13.95 | |
| Price to sales ratio | 3.58 | 21.83 | 2.38 | 1.58 | |
| POCF ratio | 100.09 | 171.46 | 33.58 | -950.44 | |
| PFCF ratio | 357.77 | 211.96 | 53.06 | -66.64 | |
| P/B Ratio | 2.6 | 16.38 | 1.64 | 1.05 | |
| PTB ratio | 2.6 | 16.38 | 1.64 | 1.05 | |
| EV to sales | 4.62 | 22.93 | 3.48 | 1.58 | |
| Enterprise value over EBITDA | 44.31 | 261.76 | 37.99 | 26.68 | |
| EV to operating cash flow | 129.16 | 180.1 | 49.08 | -950.44 | |
| EV to free cash flow | 461.7 | 222.64 | 77.56 | -66.64 | |
| Earnings yield | 0.01 | 0 | 0.02 | 0.02 | |
| Free cash flow yield | 0 | 0 | 0.02 | -0.02 | |
| Debt to equity | 0.3 | 0.2 | 0.19 | 0 | |
| Debt to assets | 0.68 | 0.67 | 0.67 | 0.66 | |
| Net debt to EBITDA | 9.97 | 12.56 | 12 | 0 | |
| Current ratio | 1.08 | 1.01 | 1 | 0.94 | |
| Interest coverage | 5.24 | 8.55 | 3.35 | 40.22 | |
| Income quality | 1.26 | 3.53 | 1.85 | -0.06 | |
| Dividend Yield | 0 | 0 | 0 | 0 | |
| Payout ratio | 0 | 0 | 0 | 0 | |
| Sales general and administrative to revenue | 0.01 | 0 | 0.01 | 0.1 | |
| Research and developement to revenue | 0 | 0 | 0 | 0 | |
| Intangibles to total assets | 0.04 | 0.04 | 0.04 | 0 | |
| Capex to operating cash flow | -0.72 | -0.19 | -0.37 | 13.26 | |
| Capex to revenue | -0.03 | -0.02 | -0.03 | -0.02 | |
| Capex to depreciation | -0.74 | -0.89 | -0.74 | -0.68 | |
| Stock based compensation to revenue | 0 | 0 | 0 | 0 | |
| Graham number | 32.56K | 4.16K | 39.35K | 34.95K | |
| ROIC | 0.04 | 0.05 | 0.02 | 0.03 | |
| Return on tangible assets | 0.01 | 0.01 | 0.01 | 0.01 | |
| Graham Net | -58.95K | -6.18K | -58.51K | -84.73K | |
| Working capital | 60.83B | 4.57B | -602.21M | -49.2B | |
| Tangible asset value | 409.01B | 415.07B | 425.84B | 0 | |
| Net current asset value | -147.2B | -154.31B | -158.94B | -180B | |
| Invested capital | 1.09 | 1 | 0.96 | 0 | |
| Average receivables | 0 | 0 | 0 | 0 | |
| Average payables | 192.51B | 198.05B | 209.41B | 0 | |
| Average inventory | 215.5B | 221.82B | 220.07B | 0 | |
| Days sales outstanding | 0 | 0 | 0 | 0 | |
| Days payables outstanding | 48.29 | 47.51 | 55.49 | 0 | |
| Days of inventory on hand | 58.01 | 56.89 | 58.31 | 0 | |
| Receivables turnover | 0 | 0 | 0 | 0 | |
| Payables turnover | 1.86 | 1.89 | 1.62 | 0 | |
| Inventory turnover | 1.55 | 1.58 | 1.54 | 0 | |
| ROE | 0.02 | 0.03 | 0.03 | 0.02 | |
| Capex per share | -895.93 | -97.39 | -914.25 | -788.37 |
Frequently Asked Questions
What is Cosmax, Inc. stock symbol ?
Cosmax, Inc. is a US stock and trading under the symbol 192820.KS
What is Cosmax, Inc. stock quote today ?
Cosmax, Inc. stock price is $56800 today.
Is Cosmax, Inc. stock public?
Yes, Cosmax, Inc. is a publicly traded company.
Company Profile
- Volume Average 77.8K
- Market Capitalization 702.3B
- Employee 1.15K
- Headquarters Seongnam-si,US
- IPO Date 2021-09-06
-
Website
https://www.cosmax.com 
Cosmax, Inc. researches, develops, produces, and sells cosmetic, health function food, and pharmaceutical products in Korea and internationally. The company offers skincare, color cosmetics, and hair care products, as well as mask sheets and eye patches. It also develops and manufactures medical supplies and devices; raw materials for cosmetic products; and functional containers and filling packaging products for cosmetics. The company was formerly known as Miroto Korea and changed its name to Cosmax, Inc. in 1994. Cosmax, Inc. was founded in 1992 and is headquartered in Hwaseong, South Korea.
